Sino Biopharmaceutical Ltd's Fiscal Year is From January To December.
The item "Debt-To-Equity-Ratio" stands at 0.3557 as of 06/30/2025, the highest value since 03/31/2024.
As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Debt To Equity Ratio" stands at 0.3557. This represents an increase of 33.81 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 22.71 percent compared to the value the year prior.
The 1 year change in percent is 22.71.
The 3 year change in percent is -8.49.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Debt To Equity Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Debt To Equity Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Debt To Equity Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Debt To Equity Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Debt To Equity Ratio | 280,205,508,085.11 |